STAT3 is often constitutively activated in many human cancer cells such as multiple myeloma, leukemia, lymphoma, and solid tumors [16, 17], which confers myeloma cells resistance to apoptosis through regulation of the anti-apoptotic protein Bcl-xL [18]. The gene discussed is STAT3; the disease is AL amyloidosis.